Full Text View
Tabular View
No Study Results Posted
Related Studies
Cabergoline Reduces OHSS
This study has been completed.
Study NCT00440258   Information provided by Instituto Valenciano de Infertilidad, Spain
First Received: February 23, 2007   Last Updated: February 26, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ovarian Hyperstimulation Syndrome
Additional conditions recognized in this trial
Syndrome
More general conditions related to this trial
Adnexal Diseases
Disease
Endocrine System Diseases
Genital Diseases, Female
Gonadal Disorders
Ovarian Diseases
Pathologic Processes
Interventions listed in this trial
Cabergoline
MR
Ultrasound
Blood Analysis
Additional drug interventions recognized in this trial
Dopamine Agonists
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antineoplastic Agents
Antiparkinson Agents
Central Nervous System Agents
Dopamine Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Instituto Valenciano de Infertilidad, Spain


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services